Cabot Co. (NYSE:CBT) Shares Bought by Strs Ohio

Strs Ohio raised its holdings in Cabot Co. (NYSE:CBT) by 31.6% during the 4th quarter, Holdings Channel reports. The firm owned 17,500 shares of the specialty chemicals company’s stock after buying an additional 4,200 shares during the quarter. Strs Ohio’s holdings in Cabot were worth $1,461,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. BlackRock Inc. grew its holdings in Cabot by 11.0% in the first quarter. BlackRock Inc. now owns 6,931,530 shares of the specialty chemicals company’s stock valued at $474,186,000 after purchasing an additional 686,769 shares during the period. Vanguard Group Inc. grew its holdings in Cabot by 0.4% in the third quarter. Vanguard Group Inc. now owns 6,361,129 shares of the specialty chemicals company’s stock valued at $440,635,000 after purchasing an additional 24,961 shares during the period. Wellington Management Group LLP grew its holdings in Cabot by 0.4% in the third quarter. Wellington Management Group LLP now owns 4,908,495 shares of the specialty chemicals company’s stock valued at $340,011,000 after purchasing an additional 20,589 shares during the period. Earnest Partners LLC boosted its stake in shares of Cabot by 2.1% in the third quarter. Earnest Partners LLC now owns 3,167,091 shares of the specialty chemicals company’s stock worth $219,384,000 after acquiring an additional 66,422 shares during the last quarter. Finally, State Street Corp boosted its stake in shares of Cabot by 3.1% in the first quarter. State Street Corp now owns 1,915,557 shares of the specialty chemicals company’s stock worth $146,808,000 after acquiring an additional 56,765 shares during the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Trading Up 1.5 %

CBT opened at $92.01 on Monday. Cabot Co. has a 12 month low of $63.73 and a 12 month high of $98.34. The stock has a market capitalization of $5.10 billion, a price-to-earnings ratio of 11.95, a PEG ratio of 0.97 and a beta of 1.28. The company has a debt-to-equity ratio of 0.74, a current ratio of 2.04 and a quick ratio of 1.30. The business has a fifty day moving average price of $88.31 and a 200 day moving average price of $79.82.

Cabot (NYSE:CBT) last released its earnings results on Monday, February 5th. The specialty chemicals company reported $1.56 EPS for the quarter, topping the consensus estimate of $1.49 by $0.07. The firm had revenue of $958.00 million during the quarter, compared to analysts’ expectations of $927.28 million. Cabot had a return on equity of 25.52% and a net margin of 11.24%. Sell-side analysts expect that Cabot Co. will post 6.58 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

CBT has been the topic of a number of research analyst reports. UBS Group lowered Cabot from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $90.00 to $87.00 in a research note on Monday, January 8th. Deutsche Bank Aktiengesellschaft lowered Cabot from a “buy” rating to a “hold” rating and lifted their price target for the stock from $88.00 to $95.00 in a research note on Thursday. Mizuho initiated coverage on Cabot in a research note on Wednesday, March 27th. They issued a “buy” rating and a $104.00 price target on the stock. Finally, StockNews.com lowered Cabot from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, February 14th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $90.17.

Insider Transactions at Cabot

In related news, EVP Jeff Ji Zhu sold 55,233 shares of the company’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $79.91, for a total value of $4,413,669.03. Following the completion of the sale, the executive vice president now directly owns 97,201 shares of the company’s stock, valued at approximately $7,767,331.91. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 3.07% of the company’s stock.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.